Lymphatic Mapping and Sentinel Node Biopsy in High-Grade Uterine Cancers
暂无分享,去创建一个
[1] F. Demirkıran,et al. Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer: A Turkish gynecologic oncology group study (TRSGO-SLN-006). , 2022, Gynecologic oncology.
[2] V. Gebski,et al. A phase III randomized clinical trial comparing sentinel node biopsy with no retroperitoneal node dissection in apparent early-stage endometrial cancer – ENDO-3: ANZGOG trial 1911/2020 , 2021, International Journal of Gynecological Cancer.
[3] J. How,et al. Sentinel lymph node biopsy in high-grade endometrial cancer: a systematic review and meta-analysis of performance characteristics. , 2021, American journal of obstetrics and gynecology.
[4] R. Zang,et al. Sentinel lymph Node mapping versus systematic pelvic lymphadenectomy on the prognosis for patients with intermediate-high-risk Endometrial Cancer confined to the uterus before surgery: trial protocol for a non-inferiority randomized controlled trial (SNEC trial) , 2021, Journal of gynecologic oncology.
[5] A. Mariani,et al. Cervical re-injection of indocyanine green to improve sentinel lymph node detection in endometrial cancer. , 2021, Gynecologic oncology.
[6] F. Ghezzi,et al. Sentinel node mapping vs. sentinel node mapping plus back-up lymphadenectomy in high-risk endometrial cancer patients: Results from a multi-institutional study. , 2021, Gynecologic oncology.
[7] E. Tanner,et al. Controversies in Sentinel Lymph Node Biopsy for Gynecologic Malignancies. , 2020, Journal of minimally invasive gynecology.
[8] G. Turashvili,et al. Assessment of Sentinel Lymph Node Biopsy vs Lymphadenectomy for Intermediate- and High-Grade Endometrial Cancer Staging , 2020, JAMA surgery.
[9] M. Morgan,et al. Patterns of use and outcomes of sentinel lymph node mapping for patients with high-grade endometrial cancer. , 2020, Gynecologic oncology.
[10] A. Weaver,et al. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial) , 2020, International Journal of Gynecological Cancer.
[11] S. Westin,et al. Implementation of a sentinel lymph node mapping algorithm for endometrial cancer: surgical outcomes and hospital charges , 2019, International Journal of Gynecological Cancer.
[12] M. Renz,et al. Sentinel Lymph Node Biopsies in Endometrial Cancer: Practice Patterns among Gynecologic Oncologists in the United States. , 2020, Journal of minimally invasive gynecology.
[13] A. Weaver,et al. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma. , 2019, Gynecologic oncology.
[14] X. Wan,et al. A Prospective Study of Sentinel Lymph Node Mapping for Endometrial Cancer: Is It Effective in High-Risk Subtypes? , 2019, The oncologist.
[15] J. Persson,et al. Pelvic Sentinel lymph node detection in High-Risk Endometrial Cancer (SHREC-trial)-the final step towards a paradigm shift in surgical staging. , 2019, European journal of cancer.
[16] K. Cadoo,et al. Sentinel lymph node mapping alone compared to more extensive lymphadenectomy in patients with uterine serous carcinoma. , 2019, Gynecologic oncology.
[17] L. Jager,et al. Risk of empty lymph node packets in sentinel lymph node mapping for endometrial cancer using indocyanine green , 2019, International Journal of Gynecological Cancer.
[18] P. Escobar,et al. Near-infrared fluorescence for detection of sentinel lymph nodes in women with cervical and uterine cancers (FILM): a randomised, phase 3, multicentre, non-inferiority trial. , 2018, The Lancet. Oncology.
[19] M. Plante,et al. Tips and tricks to improve sentinel lymph node mapping with Indocyanin green in endometrial cancer. , 2018, Gynecologic oncology.
[20] M. Schmidt-Hansen,et al. Sentinel node biopsy for diagnosis of lymph node involvement in endometrial cancer , 2018 .
[21] M. Plante,et al. Performance of sentinel lymph node (SLN) mapping in high-risk endometrial cancer. , 2017, Gynecologic oncology.
[22] C. Faloppa,et al. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer , 2017, Annals of Surgical Oncology.
[23] S. Lau,et al. Unexpected locations of sentinel lymph nodes in endometrial cancer. , 2017, Gynecologic oncology.
[24] S. Temkin,et al. The Utility of Sentinel Lymph Node Mapping in High-Grade Endometrial Cancer , 2017, International Journal of Gynecologic Cancer.
[25] J. Boggess,et al. Sentinel lymph node mapping and staging in endometrial cancer: A Society of Gynecologic Oncology literature review with consensus recommendations. , 2017, Gynecologic oncology.
[26] M. Munsell,et al. A prospective validation study of sentinel lymph node mapping for high-risk endometrial cancer. , 2017, Gynecologic oncology.
[27] C. Feltmate,et al. Sentinel lymph node mapping reduces practice pattern variations in surgical staging for endometrial adenocarcinoma: A before and after study. , 2017, Gynecologic oncology.
[28] A. Fader,et al. Sentinel lymph node assessment in endometrial cancer: a systematic review and meta‐analysis , 2017, American journal of obstetrics and gynecology.
[29] Vishnu Goutham Kota,et al. Sentinel lymph node mapping in endometrial cancer: a systematic review and meta-analysis , 2017, Oncotarget.
[30] A. Iasonos,et al. Survival of Patients with Serous Uterine Carcinoma Undergoing Sentinel Lymph Node Mapping , 2017, Annals of Surgical Oncology.
[31] A. Ivanova,et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. , 2017, The Lancet. Oncology.
[32] Sarika Gupta,et al. Sentinel lymph node mapping with staging lymphadenectomy for patients with endometrial cancer increases the detection of metastasis. , 2016, Gynecologic oncology.
[33] A. Berchuck,et al. Performance of sentinel lymph node biopsy in high-risk endometrial cancer , 2016, Gynecologic oncology reports.
[34] A. Fader,et al. Factors associated with successful bilateral sentinel lymph node mapping in endometrial cancer. , 2015, Gynecologic oncology.
[35] A. Ferenczy,et al. Comparing indocyanine green, technetium, and blue dye for sentinel lymph node mapping in endometrial cancer. , 2015, Gynecologic oncology.
[36] D. Levine,et al. Survival of Patients with Uterine Carcinosarcoma Undergoing Sentinel Lymph Node Mapping , 2015, Annals of Surgical Oncology.
[37] A. Weaver,et al. Prospective assessment of the prevalence of pelvic, paraaortic and high paraaortic lymph node metastasis in endometrial cancer. , 2014, Gynecologic oncology.
[38] R. Coleman,et al. Lymphatic mapping and sentinel lymph node biopsy in women with squamous cell carcinoma of the vulva: a gynecologic oncology group study. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] R. Barakat,et al. The importance of applying a sentinel lymph node mapping algorithm in endometrial cancer staging: beyond removal of blue nodes. , 2012, Gynecologic oncology.
[40] G. Chatellier,et al. Bilateral negative sentinel nodes accurately predict absence of lymph node metastasis in early cervical cancer: results of the SENTICOL study. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] D. Levine,et al. Improving sentinel lymph node detection rates in endometrial cancer: how many cases are needed? , 2009, Gynecologic oncology.
[42] R. Barakat,et al. The incidence of isolated paraaortic nodal metastasis in surgically staged endometrial cancer patients with negative pelvic lymph nodes. , 2009, Gynecologic oncology.
[43] M. Parmar,et al. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomised study , 2009, The Lancet.
[44] V. Torri,et al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. , 2009, Journal of the National Cancer Institute.
[45] B. Bundy,et al. Surgical pathologic spread patterns of endometrial cancer: A gynecologic oncology group study , 1987, Cancer.
[46] Patrick Neven,et al. Endometrial cancer. , 2005, Lancet.
[47] Umberto Veronesi,et al. Proceedings of the Consensus Conference on the Role of Sentinel Lymph Node Biopsy in Carcinoma of the Breast April 19–22, 2001, Philadelphia, PA, USA , 2002 .
[48] J. Wharton,et al. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high-risk endometrial cancer: results of a pilot study. , 1996, Gynecologic oncology.
[49] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.